Photodynamic therapy of experimental choroidal neovascularization in the mouse

被引:16
作者
Odergren, Anne
Ming, Yue
Kvanta, Anders
机构
[1] St Eriks Eye Hosp, Karolinska Inst, Sect Ophthalmol & Vis, Dept Clin Neurosci, SE-11282 Stockholm, Sweden
[2] Jilin Univ, Hosp 2, Dept Ophthalmol, Changchun 130023, Peoples R China
关键词
age-related macular degeneration; angiogenesis; mouse; photodynamic therapy;
D O I
10.1080/02713680600865045
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate the qualitative and quantitative effects of verteporfin photodynamic therapy (PDT) on laser-induced choroidal neovascularization (CNV) in the mouse. Methods: PDT was applied to the normal mouse fundus using light doses of 32, 64, and 83 s, and histological analysis of the treated areas was performed. CNV was induced using krypton laser photocoagulation of the fundus, and the CNV lesions were subsequently treated with PDT using light doses of 32, 64, and 83 s. Enucleated eyes were analyzed with light and transmission electron microscopies, and measurements of CNV size were done on histologic sections and on isolectin B4-stained choroidal flat mounts. Results: PDT induced a light dose-dependent damage to the surrounding neural retina in normal eyes. At a light dose of 32 s, minimal damage was detected in the neural retina, whereas higher light doses caused distortion and disruption of the outer and inner nuclear layers and of the retinal pigment epithelium. When PDT was applied over laser-induced CNV lesions, the relative height of the lesions was significantly reduced (p < 0.05) using all light doses. Transmission electron microscopy 1 day after PDT treatment revealed occlusion of many of the CNV vessels. One week after PDT treatment, the CNV lesions contained patent vessels irrespective of light dose applied. Accordingly, PDT treatment inhibited (p < 0.05) but did not halt CNV lesion growth. Conclusions: PDT treatment of laser-induced CNV may create an acute occlusion of neovessels and an inhibition of CNV lesion growth without apparent injury to the surrounding neural retina. However, PDT-treated areas will remain vascularized with continued growth of the CNV lesion, which in turn may explain the often limited effect of PDT in patients with neovascular age-related macular degeneration. Elevating the PDT light dose will not increase the treatment effect substantially but may lead to increased collateral injury.
引用
收藏
页码:765 / 774
页数:10
相关论文
共 22 条
[11]   PHOTODYNAMIC THERAPY OF EXPERIMENTAL CHOROIDAL NEOVASCULARIZATION USING LIPOPROTEIN-DELIVERED BENZOPORPHYRIN [J].
MILLER, JW ;
WALSH, AW ;
KRAMER, M ;
HASAN, T ;
MICHAUD, N ;
FLOTTE, TJ ;
HAIMOVICI, R ;
GRAGOUDAS, ES .
ARCHIVES OF OPHTHALMOLOGY, 1995, 113 (06) :810-818
[12]   Subthreshold transpupillary thermotherapy reduces experimental choroidal neovascularization in the mouse without collateral damage to the neural retina [J].
Ming, Y ;
Algvere, PV ;
Odergren, A ;
Berglin, L ;
van der Ploeg, I ;
Seregard, S ;
Kvanta, A .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (06) :1969-1974
[13]   Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy [J].
Moshfeghi, DM ;
Kaiser, PK ;
Grossniklaus, HE ;
Sternberg, P ;
Sears, JE ;
Johnson, MW ;
Ratliff, N ;
Branco, A ;
Blumenkranz, MS ;
Lewis, H .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 135 (03) :343-350
[14]   Combretastatin A-4 phosphate suppresses development and induces regression of choroidal neovascularization [J].
Nambu, H ;
Nambu, R ;
Melia, M ;
Campochiaro, PA .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (08) :3650-3655
[15]   Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization [J].
Rakic, JM ;
Lambert, V ;
Devy, L ;
Luttun, A ;
Carmeliet, P ;
Claes, C ;
Nguyen, L ;
Foidart, JM ;
Noël, A ;
Munaut, C .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (07) :3186-3193
[16]   Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey [J].
Reinke, MH ;
Canakis, C ;
Husain, D ;
Michaud, N ;
Flotte, TJ ;
Gragoudas, ES ;
Miller, JW .
OPHTHALMOLOGY, 1999, 106 (10) :1915-1923
[17]   Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2 [J].
Renno, RZ ;
Terada, Y ;
Haddadin, MJ ;
Michaud, NA ;
Gragoudas, ES ;
Miller, JW .
ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (07) :1002-1011
[18]   Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes [J].
Schlötzer-Schrehardt, U ;
Viestenz, A ;
Naumann, GOH ;
Laqua, H ;
Michels, S ;
Schmidt-Erfurth, U .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2002, 240 (09) :748-757
[19]   Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor [J].
Schmidt-Erfurth, U ;
Schlötzer-Schrehard, U ;
Cursiefen, C ;
Michels, S ;
Beckendorf, A ;
Naumann, GOH .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (10) :4473-4480
[20]   Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy [J].
Schnurrbusch, UEK ;
Welt, K ;
Horn, LC ;
Wiedemann, P ;
Wolf, S .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2001, 85 (09) :1086-1091